Kelly Farwell Gonzalez received a B.A. in Psychobiology from Scripps College (the Claremont Colleges) and a M.S. in Genetic Counseling from the University of Arizona. Prior to her graduate studies, she spent several years in a research lab studying DNA mutagenesis. She later worked for more than four years as a senior genetic counselor at the Molecular Diagnostic Laboratory at City of Hope, where she continued her involvement in research, most of which focused on Li-Fraumeni Syndrome (LFS). She has more than 15 peer-reviewed publications in molecular genetics and has been an invited lecturer at several scientific meetings. Driven by her interest in new molecular technologies, Ms. Farwell Gonzalez joined Ambry in 2009 to lead the genomic services group where she gained expertise in multiple sequencing platforms and DNA/RNA enrichment techniques. Ms. Farwell Gonzalez currently leads Ambry's emerging clinical genomics offerings, most notably, the Clinical Diagnostic Exome, which allows her to draw on her expertise in next-gen sequencing, DNA mutagenesis, and genetic counseling.